These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9241018)

  • 41. Clinical Trials for Treatment of Borderline Personality Disorder.
    Schulz SC; Black DW
    Am J Psychiatry; 2015 Aug; 172(8):793. PubMed ID: 26234601
    [No Abstract]   [Full Text] [Related]  

  • 42. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
    Leitner P; Serfling R
    Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aripiprazole treatment of patients with borderline personality disorder.
    Nickel MK
    J Clin Psychiatry; 2007 Nov; 68(11):1815-6. PubMed ID: 18052583
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of outpatients with borderline personality disorder.
    Sweeney DR
    J Clin Psychiatry; 1987 Aug; 48 Suppl():32-7. PubMed ID: 2886495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential diagnosis of coagulation abnormalities in borderline personality disorder.
    Malevani J; Mobascher J; Cordes J; Mobascher A
    World J Biol Psychiatry; 2008; 9(1):78-80. PubMed ID: 17853273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug therapy in borderline patients.
    Cole JO; Salomon M; Gunderson J; Sunderland P; Simmonds P
    Compr Psychiatry; 1984; 25(3):249-54. PubMed ID: 6145541
    [No Abstract]   [Full Text] [Related]  

  • 49. Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours.
    Ferreri MM; Loze JY; Rouillon F; Limosin F
    Eur Psychiatry; 2004 May; 19(3):177-8. PubMed ID: 15158928
    [No Abstract]   [Full Text] [Related]  

  • 50. A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder: six-month outcome.
    Gregory RJ; Remen AL; Soderberg M; Ploutz-Snyder RJ
    J Am Psychoanal Assoc; 2009 Feb; 57(1):199-205. PubMed ID: 19270255
    [No Abstract]   [Full Text] [Related]  

  • 51. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
    Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
    Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.
    Pascual JC; Soler J; Puigdemont D; Pérez-Egea R; Tiana T; Alvarez E; Pérez V
    J Clin Psychiatry; 2008 Apr; 69(4):603-8. PubMed ID: 18251623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of change in borderline personality disorder.
    Goldberg SC
    Psychopharmacol Bull; 1989; 25(4):550-5. PubMed ID: 2576568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
    Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
    Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacotherapy of borderline disorders.
    Soloff PH
    Compr Psychiatry; 1981; 22(6):535-43. PubMed ID: 6118234
    [No Abstract]   [Full Text] [Related]  

  • 56. A 27-year follow-up of patients with borderline personality disorder.
    Paris J; Zweig-Frank H
    Compr Psychiatry; 2001; 42(6):482-7. PubMed ID: 11704940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
    Kim JH; Kim D; Marder SR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacological treatment of borderline personality disorders. Several options for symptom reduction but nothing for the disorder per se].
    Rydén G; Vinnars B
    Lakartidningen; 2002 Dec; 99(50):5088-94. PubMed ID: 12572301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.
    Galynker I; Khan A; Grebchenko Y; Ten A; Malaya L; Yanowitch P; Cohen LJ
    J Clin Psychiatry; 2005 Apr; 66(4):544. PubMed ID: 15816805
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of borderline personality disorder with olanzapine.
    Shoja-Shafti S
    Arch Iran Med; 2006 Oct; 9(4):403-5. PubMed ID: 17061615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.